Agenda

Filters

Experience

Sat Jan 16

8:30 - 9:30 AM (EST)

Difficult-to-Treat Depression: What Experts Do Differently

Supported by an educational grant from Johnson & Johnson.
Many patients labeled with difficult to treat depression have not had adequate trials or a complete diagnostic workup, and escalating too soon can mean missed diagnoses and avoidable risk. This session offers a defensible definition, a structured review of diagnosis, adherence, dose adequacy, comorbidity, and missed bipolarity, and an overview of the mechanisms behind ketamine, adjunctive antipsychotics, TMS, and VNS. Attendees will leave able to document prior trials clearly and compare approved pharmacologic and neuromodulation options to build an escalation sequence for an individual patient.

Speaker

Saturday, January 16 8:30–9:30 AM
Faculty

Linda Collado

MD, DABPN, FAPA
Associate Program Director
Banyan Health Systems

Linda Collado, MD, DABPN, FAPA, is the Chief Executive Officer of Psychiatry Realm in Miami, Florida. She holds multiple academic appointments, including Associate Program Director of the Psychiatry Residency Program at Banyan Health Systems. Dr. Collado completed her fellowship in Child and Adolescent Psychiatry at Jackson Memorial Hospital/University of Miami. She is a Board-Certified Diplomate of the American Board of Psychiatry and Neurology and a Board-Certified Diplomate in Child and Adolescent Psychiatry. Dr. Collado is an active member of several professional organizations, including the American Psychiatric Association, the American Academy of Child and Adolescent Psychiatry, and the American Medical Association. She remains committed to advancing compassionate, evidence-based psychiatric care.

Faculty

Ginger Shupe

MD
Medical Director of Outpatient Psychiatry
Larkin Community Hospital

10:10 - 11:10 AM (EST)

Brunch Innovation Theater (Non-Accredited): Impact, Assessment, and Treatment of Tardive Dyskinesia: A Focus on Patient-Reported Outcomes With a VMAT2 Inhibitor

Brunch will be served. Seating is limited and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):

Scott Weiner, MD; Founder and Chief Medical Officer; Prisma Wellness; Renton, WA

This presentation is sponsored by Neurocrine Biosciences, Inc.
Saturday, January 16 10:10–11:10 AM

11:10 - 11:40 AM (EST)

Exhibit Hall (Non-Accredited)

Join your peers in the Exhibit Hall to learn about available pharmaceuticals and devices for clinical practice.
Saturday, January 16 11:10–11:40 AM

11:40 - 12:40 PM (EST)

Long-Acting Injectables in Schizophrenia: When, Why, and How to Get Better Outcomes

Despite strong evidence supporting their use, long-acting injectable antipsychotics remain underutilized in clinical practice. This session reviews the evidence, including historical data, PRELAPSE, and current guidelines, and examines the gap between clinician beliefs and patient perspectives and how framing shapes acceptance. Attendees will leave able to choose among aripiprazole, paliperidone, and risperidone LAIs by weighing pharmacokinetics, dosing intervals, missed-dose considerations, access, and clinic workflow.

Speaker

Saturday, January 16 11:40–12:40 PM
Faculty

Linda Collado

MD, DABPN, FAPA
Associate Program Director
Banyan Health Systems

Linda Collado, MD, DABPN, FAPA, is the Chief Executive Officer of Psychiatry Realm in Miami, Florida. She holds multiple academic appointments, including Associate Program Director of the Psychiatry Residency Program at Banyan Health Systems. Dr. Collado completed her fellowship in Child and Adolescent Psychiatry at Jackson Memorial Hospital/University of Miami. She is a Board-Certified Diplomate of the American Board of Psychiatry and Neurology and a Board-Certified Diplomate in Child and Adolescent Psychiatry. Dr. Collado is an active member of several professional organizations, including the American Psychiatric Association, the American Academy of Child and Adolescent Psychiatry, and the American Medical Association. She remains committed to advancing compassionate, evidence-based psychiatric care.

Faculty

Maria Collado

MD, DABPN, FAPA
Clinical Associate Professor at FIU
Citrus Health Network, Inc.

Maria Collado, M.D., FAPA, is a Clinical Associate Professor at Florida International University Herbert Wertheim College of Medicine and the Clinical Director of the Adult Crisis Stabilization Unit at Citrus Health Network in Hialeah, Florida. She is a Board-Certified Diplomate of the American Board of Psychiatry and Neurology in Psychiatry and Consultation-Liaison Psychiatry. Dr. Collado completed her fellowship in Consultation-Liaison Psychiatry at Jackson Memorial Hospital/University of Miami Miller School of Medicine. Dr. Collado has extensive experience in clinical leadership, including supervision of multidisciplinary teams, expert testimony in Mental Health Court, and the teaching and mentorship of psychiatry residents and medical students. She serves as Core Faculty for the psychiatry residency programs at Citrus Health Network and Banyan Health Systems and participates in resident clinical skills evaluations and competency assessments. She has been recognized for her excellence in medical education, including Supervisor of the Year and multiple Faculty of the Year awards. Dr. Collado is also actively involved in clinical research as a Principal Investigator and has contributed to numerous scholarly publications, posters, and presentations. Her academic interests include schizophrenia, addiction, novel psychiatric treatments, and mental health law. She is a Fellow of the American Psychiatric Association and an active member of several professional organizations, including the Florida Psychiatric Society, Miami-Dade County Medical Association, and Academy of Consultation-Liaison Psychiatry. She remains committed to advancing evidence-based psychiatric care, medical education, and clinical research.

12:50 - 1:50 PM (EST)

Psychedelics in Psychiatry: Where the Science Stands and Where It's Headed

As patients and trainees increasingly ask about psychedelic and psychedelic-adjacent therapies, clinicians need a practical framework for responding. This session covers which patients are appropriate candidates and how to screen for exclusions, how the four best-studied agents are thought to work, including receptor pharmacology, desynchronization, and plasticity. Attendees will also learn to appraise the evidence, including blinding, expectancy, and effect size, and to understand each agent's regulatory status.

Speaker

Saturday, January 16 12:50–1:50 PM
Faculty

Sasidhar Gunturu

MD, DFAPA
Vice Chair | Residency Training Director
Bronx Care Health System

Dr. Sasidhar Gunturu is a distinguished psychiatrist, educator, and healthcare leader currently serving as Vice Chair for Education, Research, and Faculty Development and Director of the Psychiatry Residency Training Program at BronxCare Health System, a role he has held since June 2021.<br><br>

Dr. Gunturu completed his medical education at NTR University of Health Sciences in India before pursuing psychiatric training in the United States. He completed his General Psychiatry Residency at the Icahn School of Medicine at Mount Sinai (Bronx Lebanon Hospital), followed by a Consultation-Liaison Psychiatry Fellowship at the University of Miami Miller School of Medicine and a Public Psychiatry Fellowship at Columbia University. He is a board-certified Diplomate of the American Board of Psychiatry and Neurology and holds academic appointments as Clinical Assistant Professor of Psychiatry at Icahn School of Medicine at Mount Sinai, Clinical Associate Professor and Clerkship Site Director at St. George's University Medical School, and Adjunct Professor of Clinical Medicine and Clerkship Site Director at the American University of Antigua Medical School. <br><br>

Beyond academia, Dr. Gunturu serves as Medical Director for Psychiatric Integrated Services & Community Psychiatry at BronxCare and Consulting Chief Behavioral Health Officer at Essen Health Care, overseeing behavioral health delivery for underserved South Bronx populations. <br><br>

Nationally, Dr. Gunturu serves as President-Elect of the APA's Bronx District Branch and is a Distinguished Fellow of the American Psychiatric Association. His committee work includes the APA Council on Healthcare Systems and Financing, the APA Psychiatric Services Award Selection Committee, the Academy of Consultation-Liaison Psychiatry's Guidelines and Evidence-Based Medicine and Research Subcommittees, and the Curriculum Committee of the American Academy of Directors in Psychiatry Residency Training. Institutionally, he chairs BronxCare's Wellness Committee and serves on its Medical Executive Committee, Credentialing Committee, IRB, Ethics Committee, and GME Committee. <br><br>

An accomplished scholar, Dr. Gunturu has authored more than 50 peer-reviewed publications, delivered over 90 conference presentations, and holds editorial and peer-review roles with leading psychiatric journals. His honors include the Outstanding Resident of the Year Award from the American Psychiatric Association and the BronxCare Teacher of the Year Award. He previously served as Chief Resident in the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai, an early marker of his leadership trajectory.<br><br>

Widely regarded as a mentor to emerging psychiatrists, Dr. Gunturu remains focused on research innovation, faculty development, and expanding equitable mental health access. His breadth spanning residency education, community psychiatry, and national leadership makes him an authoritative voice on the future of psychiatric training. Outside of medicine, he enjoys traveling, Scuba diving, jet skiing, and spending time with his dog.

Faculty

Manish Zinzuvadia

MD
Medical Director
Park Avenue Wellness Center

Dr. Zinzuvadia is the founder and director of Park Avenue Wellness Center and is board certified in both Adult and Geriatric psychiatry. He directs the psychiatric services of several residential treatment facilities while also managing a comprehensive outpatient practice in Manhattan's Upper East Side.

He received his M.D. from SUNY Downstate College of Medicine and completed his residency training in psychiatry at New York Medical College in Valhalla, NY. He completed fellowship training in geriatric psychiatry at Weill Cornell Medical College.

He has implemented programs using long acting antipsychotic injections to decrease hospital readmission rates for treatment resistant schizophrenic patients across New York. He has an expertise in treating elderly patients both in the office setting and using in-home visits. He has been able to work with families to keep patients stable and at home instead of being placed into nursing facilities.

Dr. Zinzuvadia's research and clinical interests include the use of long acting antipsychotics in treatment resistant patients, cognitive dysfunction and treatment resistant depression in older adults, and the role of novel psychopharmacological agents including ketamine infusions in treatment resistant mood disorders. He is also helping to pioneer the use of technological interventions to increase access to quality psychiatric care. He directs a program for treatment resistant depression at the Park Avenue Wellness Center using a combination of comprehensive assessment and psychopharmacology, IV Ketamine infusions, and psychotherapy.

2:20 - 3:20 PM (EST)

Late Lunch Innovation Theater (Non-Accredited): Expanding Our Perspectives: Discover a Unique Treatment Option for Adults with Schizophrenia

Late lunch will be served. Seating is limited and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):

Todd Broder, MD; Medical Director University of Florida St. John's (Flagler Hospital)

This presentation is sponsored by Bristol Myers Squibb.
Saturday, January 16 2:20–3:20 PM

3:20 - 3:50 PM (EST)

Exhibit Hall (Non-Accredited)

Join your peers in the Exhibit Hall to learn about available pharmaceuticals and devices for clinical practice.
Saturday, January 16 3:20–3:50 PM

3:50 - 4:50 PM (EST)

Muscarinic Approaches in Schizophrenia: New Directions in Treatment to Address Unmet Needs

Supported by an educational grant from Bristol-Myers Squibb.
The treatment landscape for schizophrenia is expanding beyond traditional dopamine D2 receptor blockade, with muscarinic receptor-targeting therapies offering novel approaches to symptom management. This session will review the limitations of conventional antipsychotics, the science behind muscarinic receptor modulation, and the latest clinical data on available and emerging agents. Through expert insights and practical case-based discussion, participants will gain strategies for patient selection, treatment initiation, adverse effect management, and patient-centered communication to support the integration of these therapies into clinical practice.

Speaker

Saturday, January 16 3:50–4:50 PM
Program Chair

Ilan Melnick

MD
Chief Medical Officer, Passageway Residences of Dade County,
Passageway Residences of Dade County

Ilan Melnick, MD, is the primary psychiatrist in two outpatient clinics in the Miami, Florida area, as well as a staff psychiatrist and Chief Medical Officer at Passageway Residences of Miami-Dade County. In addition, Dr. Melnick is a staff psychiatrist and Medical Director for Jewish Community Services and performs independent medical and psychiatric evaluations for Miami-Dade County police, fire, transit and aviation departments.

Dr. Melnick received his medical degree in Bayamon, Puerto Rico and went on to do his residency in psychiatry and fellowship in geriatric psychiatry at the University of Miami/Jackson Memorial Hospital.He continues to be involved in education as an Assistant Professor at Florida International University School of medicine. He continues to be involved in education through his role giving grand rounds at major universities and hospitals around the world.

Faculty

Howard Pratt

DO, MBA
Psychiatrist and Behavioral Health Medical Director
Community Health of South Florida, Inc.

Dr. Howard Pratt is a board-certified psychiatrist and child and adolescent psychiatrist whose career bridges clinical practice, healthcare administration, and health policy. He serves as medical director of psychiatric services at Community Health of South Florida Inc as well as in his private practice, maintaining an active clinical role across both adult and pediatric populations.

He is graduate of Northwestern university Kellogg School of Management and serves as a physician executive, a dual role that allows him to inform organizational and operational decision-making with clinical expertise while remaining engaged in day-to-day psychiatric practice. This combination of administrative and clinical perspective has positioned him as a valued voice on questions of care delivery, quality, and systems design within psychiatric health.
He serves on the National Boards, contributing to the credentialing and policy frameworks that help establish national standards of practice across the field, and holds committee appointments with the National Association of Community Health Centers (NACHC), where his work centers on expanding access to behavioral health services within underserved and community-based populations. This reflects a sustained professional interest in community health and health equity as core components of psychiatric care.
In addition to his clinical and administrative responsibilities, Dr. Pratt provides consulting services to healthcare organizations and community health systems, advising on the integration of behavioral health into broader care models and the development of sustainable approaches to psychiatric service delivery. His work consistently reflects a commitment to aligning clinical excellence with practical, system-level solutions.

5:00 - 6:30 PM (EST)

Poster Reception (Non-Accredited)

Join the Psych Congress Clinical Pearls Faculty, attendees, and peers for a poster reception with live music, hors d'oeuvres, and cocktails.
Saturday, January 16 5:00–6:30 PM

Sun Jan 17

8:30 - 9:30 AM (EST)

Catching It Early, Managing It Right: Cognitive Decline and Agitation in Real-World Practice

Diagnosing dementia and managing agitation have both changed, with biomarker-based criteria and blood tests reshaping the workup and new options expanding treatment. This session covers distinguishing normal aging, MCI, and the major dementia syndromes, building a diagnostic workup, and the amyloid, tau, cholinergic, glutamatergic, and agitation neurobiology behind current therapies. Attendees will leave able to apply a stepwise approach to agitation, from reversible causes and non-pharmacologic strategies through a comparison of the FDA-approved pharmacologic options.

Speaker

Sunday, January 17 8:30–9:30 AM
Steering Committee Partner

Marc Agronin

MD
Chief Medical Officer, MIND Institute and Behavioral Health
Miami Jewish Health

Marc E. Agronin, MD, is a board-certified adult and geriatric psychiatrist and currently works as the Chief Medical Officer for the Frank C. and Lynn Scaduto MIND Institute and for Behavioral Health at Miami Jewish Health. He is an Affiliate Associate Professor of Psychiatry and Neurology at the University of Miami Miller School of Medicine. Dr. Agronin is a graduate of Harvard University, summa cum laude, and the Yale School of Medicine. He completed his residency training in adult psychiatry at Harvard University's McLean Hospital and then a geriatric psychiatry fellowship at the Minneapolis VA Medical Center. Dr. Agronin is the 2008 recipient of the "Clinician of the Year" award from the American Association for Geriatric Psychiatry (AAGP) and is a Distinguished Fellow of the American Psychiatric Association and the AAGP. Dr. Agronin is a national expert in Alzheimer's disease and geriatric mental health, and is the author of the acclaimed books "How We Age: A Doctor's Journey into the Heart of Growing Old" (2011) and "The End of Old Age: Living a Longer, More Purposeful Life" (2018). Dr. Agronin has written nine other books and hundreds of articles, including "The Dementia Caregiver: A Guide to Caring for Someone with Alzheimer's Disease and Other Neurocognitive Disorders" (2015). He has been published in The New York Times and writes regular articles on aging, health and retirement issues for The Wall Street Journal.

Faculty

Patricia Junquera

MD, FAPA
Chair, Associate Professor
Florida International University | AHC1 349

Patricia Junquera, M.D., is Chair of the Department of Psychiatry and Behavioral Health at Florida International University’s Herbert Wertheim College of Medicine. She is a board-certified psychiatrist with specialized training in adult and geriatric psychiatry and extensive experience in academic medicine, clinical leadership, medical education, and the development of innovative behavioral health programs.

Dr. Junquera completed her psychiatry residency in Miami and pursued fellowship training in Geriatric Psychiatry. Throughout her career, she has held leadership positions across diverse clinical settings, including academic medical centers, the Veterans Affairs system, correctional health, inpatient and outpatient services, and graduate medical education. She has played a key role in developing psychiatric training programs, consultation-liaison services, and standardized approaches to mental health care.

At FIU, Dr. Junquera leads initiatives focused on expanding access to high-quality psychiatric care, strengthening medical education, supporting faculty development, and advancing innovative treatments. She has been instrumental in developing neuromodulation services, including repetitive transcranial magnetic stimulation (rTMS) and esketamine treatment for treatment-resistant depression, while supporting the expansion of additional interventional psychiatric services.

Her clinical and academic interests include geriatric psychiatry, depression, Alzheimer’s disease and related dementias, neuromodulation, mental health innovation, and emerging technologies in psychiatry. Dr. Junquera is also deeply committed to reducing mental health stigma and increasing community education. Through leadership, mentorship, clinical innovation, and public engagement, she works to strengthen behavioral health services while preparing the next generation of physicians and mental health professionals.

Program Chair

Ilan Melnick

MD
Chief Medical Officer, Passageway Residences of Dade County,
Passageway Residences of Dade County

Ilan Melnick, MD, is the primary psychiatrist in two outpatient clinics in the Miami, Florida area, as well as a staff psychiatrist and Chief Medical Officer at Passageway Residences of Miami-Dade County. In addition, Dr. Melnick is a staff psychiatrist and Medical Director for Jewish Community Services and performs independent medical and psychiatric evaluations for Miami-Dade County police, fire, transit and aviation departments.

Dr. Melnick received his medical degree in Bayamon, Puerto Rico and went on to do his residency in psychiatry and fellowship in geriatric psychiatry at the University of Miami/Jackson Memorial Hospital.He continues to be involved in education as an Assistant Professor at Florida International University School of medicine. He continues to be involved in education through his role giving grand rounds at major universities and hospitals around the world.

10:10 - 11:10 AM (EST)

Brunch Innovation Theater (Non-Accredited): When Antidepressants Aren’t Enough: Understanding Unmet Needs as Drivers of Treatment Strategy

Brunch will be served. Seating is limited and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):

Rakesh Jain, MD, MPH; Texas Tech University School of Medicine; Permian Basin, Department of Psychiatry; Midland, Texas; Private Practice; Carrollton, Texas

This presentation is sponsored by Johnson and Johnson.
Sunday, January 17 10:10–11:10 AM

11:10 - 11:40 AM (EST)

Exhibit Hall (Non-Accredited)

Join your peers in the Exhibit Hall to learn about available pharmaceuticals and devices for clinical practice.
Sunday, January 17 11:10–11:40 AM

11:40 - 12:40 PM (EST)

The Missing Pieces of ADHD: Practical Pearls for Clinical Practice

Attention-deficit/hyperactivity disorder (ADHD) extends beyond its classic presentation and often presents diagnostic and treatment challenges across the lifespan. This session applies DSM-5-TR criteria across the lifespan, links the underlying circuitry and catecholamine signaling to how stimulants and non-stimulants work, and distinguishes methylphenidate from amphetamine and compares the approved non-stimulants. Attendees will leave able to select and titrate treatment by age, comorbidity, and delivery system, and to describe agents approved or in development as of 2026.

Speaker

Sunday, January 17 11:40–12:40 PM
Steering Committee

Brittany Albright

MD, MPH, DABOM
Founder and Medical Director of Multidisciplinary and Interventional Psychiatry Practice
Sweetgrass Psychiatry; Medical University of South Carolina

Brittany Albright, MD, MPH, is a Harvard-trained, triple board-certified psychiatrist with expertise in interventional psychiatry, addiction psychiatry, and obesity medicine. She completed her adult psychiatry residency at Massachusetts General Hospital and McLean Hospital, followed by fellowship training in Addiction Psychiatry at the Medical University of South Carolina (MUSC). She currently serves as an Affiliate Assistant Professor of Psychiatry at MUSC.

Dr. Albright is the Founder and CEO of Sweetgrass Psychiatry, South Carolina’s largest physician-owned psychiatry practice, with three locations and a multidisciplinary team of 25+ clinicians. A leader in advancing access to innovative care, Sweetgrass Psychiatry was the first practice to launch esketamine in South Carolina in 2019 and has since developed a comprehensive interventional psychiatry program incorporating esketamine, ketamine, long acting injectables, and transcranial magnetic stimulation.

Her academic work includes numerous abstracts presented at national meetings and peer-reviewed publications spanning innovative psychiatric treatments and medical education. A nationally recognized speaker and consultant, Dr. Albright serves as President of the South Carolina Psychiatric Association and holds multiple leadership roles with Psych Congress, including Co-Chair of Psych Congress Elevate. She also created the Private Practice Summit, a national educational program focused on advancing independent psychiatric practice.

Her clinical approach integrates psychodynamic psychotherapy, mentalization-based therapy, and motivational interviewing with evidence-based pharmacologic and interventional treatments. She enjoys treating patients across the spectrum of psychiatric illness, with particular interests in complex mood and psychotic disorders and substance use disorders. She is trained and certified in transcranial magnetic stimulation and psychedelic-assisted psychotherapy.

Program Chair

Ilan Melnick

MD
Chief Medical Officer, Passageway Residences of Dade County,
Passageway Residences of Dade County

Ilan Melnick, MD, is the primary psychiatrist in two outpatient clinics in the Miami, Florida area, as well as a staff psychiatrist and Chief Medical Officer at Passageway Residences of Miami-Dade County. In addition, Dr. Melnick is a staff psychiatrist and Medical Director for Jewish Community Services and performs independent medical and psychiatric evaluations for Miami-Dade County police, fire, transit and aviation departments.

Dr. Melnick received his medical degree in Bayamon, Puerto Rico and went on to do his residency in psychiatry and fellowship in geriatric psychiatry at the University of Miami/Jackson Memorial Hospital.He continues to be involved in education as an Assistant Professor at Florida International University School of medicine. He continues to be involved in education through his role giving grand rounds at major universities and hospitals around the world.

Faculty

Manish Zinzuvadia

MD
Medical Director
Park Avenue Wellness Center

Dr. Zinzuvadia is the founder and director of Park Avenue Wellness Center and is board certified in both Adult and Geriatric psychiatry. He directs the psychiatric services of several residential treatment facilities while also managing a comprehensive outpatient practice in Manhattan's Upper East Side.

He received his M.D. from SUNY Downstate College of Medicine and completed his residency training in psychiatry at New York Medical College in Valhalla, NY. He completed fellowship training in geriatric psychiatry at Weill Cornell Medical College.

He has implemented programs using long acting antipsychotic injections to decrease hospital readmission rates for treatment resistant schizophrenic patients across New York. He has an expertise in treating elderly patients both in the office setting and using in-home visits. He has been able to work with families to keep patients stable and at home instead of being placed into nursing facilities.

Dr. Zinzuvadia's research and clinical interests include the use of long acting antipsychotics in treatment resistant patients, cognitive dysfunction and treatment resistant depression in older adults, and the role of novel psychopharmacological agents including ketamine infusions in treatment resistant mood disorders. He is also helping to pioneer the use of technological interventions to increase access to quality psychiatric care. He directs a program for treatment resistant depression at the Park Avenue Wellness Center using a combination of comprehensive assessment and psychopharmacology, IV Ketamine infusions, and psychotherapy.

12:50 - 1:50 PM (EST)

Moving From Missed to Managed: Evidence-Based Recognition and Treatment of Tardive Dyskinesia

Supported by an educational grant from Neurocrine Biosciences, Inc.
Tardive dyskinesia (TD) is often missed or mistaken for other drug-induced movement disorders, even though most clinicians who prescribe antipsychotics will encounter it. This session covers how to recognize TD and tell it apart from acute extrapyramidal symptoms, how to apply AIMS-based screening across outpatient, inpatient, telehealth, and long-term care settings, and the pathophysiology behind prevention, risk mitigation, and supportive management. Attendees will leave able to evaluate FDA-approved treatments, including VMAT2 inhibitors, by weighing patient-specific factors, formulation, safety, tolerability, and real-world evidence.

Speaker

Sunday, January 17 12:50–1:50 PM
Faculty

Juan Oms

MD
Residency Program Director
Southern Winds Hospital

Dr. Juan Oms completed medical school at Autonomous University of Guadalajara (UAG) in Jalisco, Mexico and completed his residency training in Psychiatry in Miami, at Jackson Memorial Hospital in association with the University of Miami and the VA Medical Center. Subsequently, Dr. Oms completed a fellowship in Forensic Psychiatry. Upon graduating he wanted to follow his passion in administrative medicine and after demonstrating his leadership skills he was named Medical Director at New Horizons Community Mental Health Center from 2009 to 2013. While also pursued a concierge outpatient treatment where he was the Medical Director for Miami Outpatient Detox.
Dr. Oms has been actively involved in residency training and education as well while being the Chairman and Program Director of Psychiatry Residency Program at Larkin Community Hospital from 2013 to 2017. Currently, is the founding Residency Program Director for Southern Winds Psychiatry Program. and is also Assistant Clinical Professor at: FIU College of Medicine.
Dr. Oms developed an interest in interventional Psychiatry and served as the Director of Psychiatry for Ketamine Health Centers from 2019 till 2022 where he spearheaded ketamine IV and TMS center. He has been involved throughout his career in clinical research as principal investigator and sub principal investigator. And, he has served at the Dade County Medical Association Executive Commitee as Treasurer/Secreratry
Dr. Oms continued his passion for the administrative aspect of medicine and currently is the Chief Medical Officer at AGAPE Network, spearheading a 120 bed residential substance and meant health facility.

2:20 - 3:20 PM (EST)

Late Lunch Innovation Theater (Non-Accredited): An Established Antipsychotic, Now Available as a Subcutaneous Injection

Late lunch will be served. Seating is limited and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):

Rakesh Jain, MD, MPH; Clinical Professor, Department of Psychiatry; Texas Tech University School of Medicine - Permian Basin; Midland, Texas

This presentation is sponsored by Teva Pharmaceuticals, Inc.
Sunday, January 17 2:20–3:20 PM

3:20 - 3:50 PM (EST)

Exhibit Hall (Non-Accredited)

Join your peers in the Exhibit Hall to learn about available pharmaceuticals and devices for clinical practice.
Sunday, January 17 3:20–3:50 PM

3:50 - 4:50 PM (EST)

Bipolar Disorder: Diagnosis, Mechanism, and the Evolving Treatment Landscape

Supported by an educational grant from Johnson & Johnson.
Bipolar depression is often misdiagnosed as unipolar depression, and that error shapes everything that follows in treatment. This session applies DSM-5-TR criteria to distinguish bipolar I, bipolar II, and mixed features, connects current pathophysiology models to the pharmacology of lithium, anticonvulsants, and second-generation antipsychotics, and previews long-acting injectables and late-stage agents in development for bipolar I. Attendees will leave able to match FDA-approved treatments to acute mania, bipolar depression, or maintenance and compare agents on efficacy and tolerability.

Speaker

Sunday, January 17 3:50–4:50 PM
Steering Committee

Brittany Albright

MD, MPH, DABOM
Founder and Medical Director of Multidisciplinary and Interventional Psychiatry Practice
Sweetgrass Psychiatry; Medical University of South Carolina

Brittany Albright, MD, MPH, is a Harvard-trained, triple board-certified psychiatrist with expertise in interventional psychiatry, addiction psychiatry, and obesity medicine. She completed her adult psychiatry residency at Massachusetts General Hospital and McLean Hospital, followed by fellowship training in Addiction Psychiatry at the Medical University of South Carolina (MUSC). She currently serves as an Affiliate Assistant Professor of Psychiatry at MUSC.

Dr. Albright is the Founder and CEO of Sweetgrass Psychiatry, South Carolina’s largest physician-owned psychiatry practice, with three locations and a multidisciplinary team of 25+ clinicians. A leader in advancing access to innovative care, Sweetgrass Psychiatry was the first practice to launch esketamine in South Carolina in 2019 and has since developed a comprehensive interventional psychiatry program incorporating esketamine, ketamine, long acting injectables, and transcranial magnetic stimulation.

Her academic work includes numerous abstracts presented at national meetings and peer-reviewed publications spanning innovative psychiatric treatments and medical education. A nationally recognized speaker and consultant, Dr. Albright serves as President of the South Carolina Psychiatric Association and holds multiple leadership roles with Psych Congress, including Co-Chair of Psych Congress Elevate. She also created the Private Practice Summit, a national educational program focused on advancing independent psychiatric practice.

Her clinical approach integrates psychodynamic psychotherapy, mentalization-based therapy, and motivational interviewing with evidence-based pharmacologic and interventional treatments. She enjoys treating patients across the spectrum of psychiatric illness, with particular interests in complex mood and psychotic disorders and substance use disorders. She is trained and certified in transcranial magnetic stimulation and psychedelic-assisted psychotherapy.

Faculty

Yanko Enamorado

MD
Psychiatrist
Mount Sinai Medical Center
Faculty

Manish Zinzuvadia

MD
Medical Director
Park Avenue Wellness Center

Dr. Zinzuvadia is the founder and director of Park Avenue Wellness Center and is board certified in both Adult and Geriatric psychiatry. He directs the psychiatric services of several residential treatment facilities while also managing a comprehensive outpatient practice in Manhattan's Upper East Side.

He received his M.D. from SUNY Downstate College of Medicine and completed his residency training in psychiatry at New York Medical College in Valhalla, NY. He completed fellowship training in geriatric psychiatry at Weill Cornell Medical College.

He has implemented programs using long acting antipsychotic injections to decrease hospital readmission rates for treatment resistant schizophrenic patients across New York. He has an expertise in treating elderly patients both in the office setting and using in-home visits. He has been able to work with families to keep patients stable and at home instead of being placed into nursing facilities.

Dr. Zinzuvadia's research and clinical interests include the use of long acting antipsychotics in treatment resistant patients, cognitive dysfunction and treatment resistant depression in older adults, and the role of novel psychopharmacological agents including ketamine infusions in treatment resistant mood disorders. He is also helping to pioneer the use of technological interventions to increase access to quality psychiatric care. He directs a program for treatment resistant depression at the Park Avenue Wellness Center using a combination of comprehensive assessment and psychopharmacology, IV Ketamine infusions, and psychotherapy.

Mattingly Photo

Agenda Highlights

The agenda for Psych Congress Clinical Pearls focuses on the diagnosis and management of complex conditions, including major depressive disorder, schizophrenia, ADHD, and more. Through expert-led, case-based sessions and interactive discussion, Clinical Pearls translates emerging evidence into practical clinical decision-making. Expert faculty and academic leaders is psychopharmacology will share how they approach diagnosis, treatment, and complex cases in real-world practice, providing attendees with high-yield insights and actionable strategies that extend beyond traditional guidelines and textbooks.

attendee

CE Information

This educational activity is intended for psychiatry residents/fellows and other healthcare professional students who seek to improve the care of patients with mental health disorders.

Back to top